Albany Molecular Research
Mar 3, 2017

AMRI to Present at Barclays Global Healthcare Conference

ALBANY, N.Y., March 3, 2017 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer, will present at the Barclays Global Healthcare Conference on Thursday, March 16, 2017 at 10:45 a.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor Relations website at http://ir.amriglobal.com/events.cfm?CalendarID=2     

The webcast will be archived for 90 days following the live presentation.

About AMRI
Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP), and Fine Chemicals. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).

Contacts

Investors
Patty Eisenhaur
AMRI Investor Relations
518.512.2936
patty.eisenhaur@amriglobal.com

Media
Gina Rothe
AMRI Communications
518-512-2512
gina.rothe@amriglobal.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amri-to-present-at-barclays-global-healthcare-conference-300417019.html

SOURCE AMRI

News Provided by Acquire Media